# Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke

> **NCT03192332** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 410 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DEVICE:** Stent-retriever thrombectomy with revascularization device of the Solitaire™ type
- **DRUG:** Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA)

## Key facts

- **NCT ID:** NCT03192332
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2021-05-14
- **Final completion:** 2021-08-11
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03192332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03192332, "Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03192332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*